Metcash chiefs Douglas Jones (left) and Grant Ramage face the ACCC inquiry into supermarkets. (Supplied by Australian Competition and Consumer Commission/AAP PHOTOS) This occasionally extended to ...

B. Riley reiterates a Buy rating on Altimmune (ALT) with a $20 price target following the Q3 report. The company provided key pipeline updates ...

A key update since then is that Pemvidutide’s MOMENTUM trial for obesity finished its Phase 2 trial in June 2024. They also ...

Altimmune, Inc. (NASDAQ:ALT) Q3 2024 Earnings Call Transcript November 12 ... 2 meeting on a comprehensive Phase 3 ...

Altimmune ( (ALT) ) has released its Q3 earnings. Here is a breakdown of the information Altimmune presented to its investors. Altimmune, Inc.

That said, split keyboards, while still niche, are nothing new. Taking things further, the Flow system goes all out on ...

The Copilot key will appear on Copilot+ PC keyboards going forward, but some people don't use Copilot and would prefer to not give up a key on their keyboard. Those people are in luck, as it is now ...

The combination of THIO and Libtayo has shown promising results among patients with advanced checkpoint inhibitor-resistant ...

It's that time of the month again Patch Tuesday is here, meaning every supported version of Windows is getting updates today ...

I was overjoyed when I first saw the Clicks Keyboard Case. It's the first-of-its-kind iPhone case with a built-in physical keyboard—yes, in 2024! I remember ferociously typing a ...

This enthusiastic recommendation is likely a key catalyst for the surge, sparking investor interest in the clinical-stage biopharmaceutical company. UBS’s rating aligns with several recent positive ...

I’m not saying the right keybind setup will secure you more Victory Crowns in Fortnite, but it’ll definitely help.